学校首页 公共卫生学院 ·设为首页·院长信箱·管理信箱
丁振华

发布时间:2014-07-21 17:07:51 作者:

照 片:

丁振华.jpg

 
 
职 称:
教授 博导
通信地址:
广州市南方医科大学公共卫生与热带医学学院放射医学系
Email:
dingzh@fimmu.com
职 务:
放射医学系主任
职称级别:
正高
学术任职:
广东省医学会放射防护医学分会主任委员,中华医学会放射医学与防护专业委员会常委,广东省社会学会常委,等
最高学历:
博士
所属科室:
放射医学系
研究方向:
1.miRNA在细胞应激反应信号转导中的调节作用;2.放射卫生与放射防护技术;3.核与放射事
科研项目:
近三年负责课题
国家自然科学基金(30970673、81172634);
广东省自然科学基金(9151022501000013);
教育部博士点基金项目(20094433110004)。等。
成果奖励:
近三年没有成果和奖励。
代表论文:
一、主编、参编多部学术著作,共110万字。
二、主要论文
1.Ding Zhenhua, et al. Inhibitory effect of china
green tea polyphenol on the oxidative modification of
low density lipoprotein by macrophage. Med Sci Res
1991; 19(22):767-768
2.Ding Z, Parchment RE, LoRusso PM, et al. The
investigational new drug XK469 induces G2-M cell cycle
arrest by p53-dependent and –independent pathways.
Clin Cancer Res 2001;7:3336
3.Wu GS & Ding Z. Caspase 9 is required for p53-
dependent apoptosis and chmosensitivity in a human
ovarian cencer cell line. Oncogene 2002; 21(1):1
4.Zhenhua Ding, Jun-Ying Zhou, Wei-Zen Wei, Vicki V
Baker and Gen Sheng Wu. Induction of apoptosis by the
new anticancer drug XK469 in human ovarian cancer cell
lines. Oncogene 2002;21:4530
5.Jing Jiao, Hong Cao, Zhen-hua Ding.
EJGH 2007;19(12):1114
6.Ling Guo, Zhong-Xi Huang, Xiao-Wei Chen, Qin-Kai Deng
and Zhen-Hua Ding.Photochem Photobiol, 2009; 85: 765
7.Fang Gao, Xiaoqun Duan, Xi Lu, Yongming Liu, Li Zheng,
Zhenhua Ding, Jun Li. Novel binding between pre-
membrane protein and claudin-1 is required for
efficient dengue virus entry. BBRC, 2010; 391:952
8.Mei-Juan ZHOU, Wei-Ling LIU, Ling GUO, Li ZHENG, Chao
LV, Li-Hong JIANG, Cheng-Shan OU and Zhen-Hua DING.
Differential Responses to UVB Irradiation in Human
Keratinocytes and Epidermoid Carcinoma Cells1. Biomed
Envirm Sci,2012;21(5):583
9.Meijuan Zhou; Weilin Liu; Shudong Ma; Hong Cao;
Xuebiao Peng; Ling Guo; Xinghua Zhou; Li Zhen; Linlang
Guo; Miaojian Wan; Weimin Shi; Yingjie He; Chao Lu;
Lihong Jiang; Chenshan Ou; Yuanxia Guo; Zhenhua Ding.A
Novel OncomiR-365 Induces Cutaneous Squamous Cell
Carcinoma.Carcinogenesis, 2013; 34(7):1653
10.Meijuan Zhou, Liang Zhou, Li Zheng, Ling Guo, Yinghui
Wang, Hongxia Liu, Chengshan Ou & Zhenhua Ding.miR-365
Promotes Cutaneous Squamous Cell Carcinoma
(CSCC) through Targeting Nuclear Factor I/B (NFIB).
PLoSONE,2014;E96):e100620.doi:10.1371/journal.pone.0100620